Discover how personalized treatments crafted with cultural sensitivity and cutting-edge science can enhance patient outcomes and how collaborations in tech and advocacy can pave the way for earlier, more effective cancer interventions.
Explore the delicate balance between technological efficiency and the personal touch crucial in health experiences. Panelists will discuss the innovative approaches they’re taking to synergize human empathy with AI to create hyper-personalized communications that respect individual preferences and cultural contexts.
A health economist, blogger, two-time author, and keynote speaker, Jane Sarasohn-Kahn is a renowned leader in the healthcare space. On this episode, she discusses health citizenship, its potential impact on the upcoming election, the continuous evolution of technology and healthcare, and what she’s most looking forward to in the future.
Discover the cutting-edge world of RNA interference (RNAi) therapeutics with Dr. Akshay Vaishnaw, Chief Innovation Officer at Alnylam Pharmaceuticals. In this episode, Dr. Vaishnaw sheds light on the groundbreaking concept of RNAi therapeutics, offering a powerful new approach to treating a wide range of diseases. Learn how Alnylam Pharmaceuticals is revolutionizing healthcare with its unwavering commitment to innovation, despite facing numerous setbacks and challenges along the way.
Want to know what it takes to create award-winning work in healthcare advertising? Check out our final Cannesplaining Healthcare podcast episode, live from the 2024 Cannes Lions International Festival of Creativity, featuring our 21GRAMS, a part of Real Chemistry, creative leaders as they explore the intersection of creativity, marketing and healthcare. Discover how to make your health advertising stand out with insights from Real Chemistry Chief Creative Officer & 21GRAMS Managing Founder F...
Live from the 2024 Cannes Lions International Festival of Creativity, join us as we explore the intersection of creativity, marketing and healthcare during our latest Cannesplaining Healthcare podcast episode featuring Genentech Chief Marketing Officer (CMO) Dr. Erica Taylor, 21GRAMS Managing Founder & Real Chemistry Chief Creative Officer Frank Mazzola, and 21GRAMS Executive Creative Director Lauren Pollina. Discover how Genentech is modernizing marketing in the pharmaceutical industry and ...
Live from the 2024 Cannes Lions International Festival of Creativity, join us for a discussion on the future of healthcare innovation and creativity. In this episode, Collette Douaihy, Dentsu Health Global CCO and President of Cannes Lions 2024 Pharma Jury, 21GRAMS Global CCO Tom Richards and 21GRAMS Executive Creative Director Chris Charles delve into the importance of patient-centricity, building strong client relationships and the ethical use of AI in healthcare. Discover insights on how to c...
In the lead up to ASCO 2024, we hosted a discussion on the dynamic landscape of oncology today, looking through the lens of this year’s meeting theme: the art and science of cancer care. Within two featured mini panels, we reviewed key trends and innovations and highlighted how intersections between art and science can help us change the face and future of the cancer experience. Touching on areas like advocacy, AI, screening and therapeutic advances, this can’t miss conversation will help us env...
Health worker burnout is soaring. A global shortage of providers, an aging population and more complicated Medicare requirements, has increased stress and exhaustion for HCPs. Innovative solutions are needed to ensure high-quality patient care and a sustainable health system. This panel will discuss how AI is helping alleviate pressure on providers while still prioritizing patient privacy and safety. From summarizing journals, to asking an AI agent about dosing or side effects, AI is removing fr...
With innovative new approaches to diagnosis and treatment in oncology, the cancer mortality rate has dropped year over year for the last decade. But there is still work to be done, especially as we see increasing cancer incidence among certain populations. But what work is happening today that will shape the face of cancer and the patient experience in the future? Wendy Short Bartie (Bristol Myers Squibb), Maimah Karmo (Tigerlily Foundation), and Emily Poe (Real Chemistry) bring together a tapes...
While there is undeniable hope for the future of cancer care, systemic barriers still impact access for many patients – particularly those in underserved communities. This session, originally recorded in front of a live audience at SXSW 2024, examines how increasing collaboration and partnerships among organizations that touch all aspects of the cancer journey and reach patients, providers and treatment centers, is critical to expanding access to optimal cancer care and making the goals of the “...
In this episode, Suzanne Jacobs, Group President of Medical at Real Chemistry, and Trina Stonner, President of Avant Healthcare, discuss Real Chemistry’s newly announced acquisition of Avant Healthcare, how the two companies came together and have similar ethos of supporting physicians in advancing patient care, and how the future of medical communications will involve a combination of data, creativity, AI, and human expertise.
It's time to talk about cancer prevention and early detection. Join us as we explore the importance of early detection and prevention in the fight against cancer with Dr. Karen Knudsen, CEO of the American Cancer Society, and Jim Weiss, Founder and Chairman at Real Chemistry. Tune in to learn about the role of the American Cancer Society in research, advocacy and patient support, the importance of genetic testing in understanding cancer risk and the future of cancer testing and the role of AI.
Listen to our latest podcast with Peter Lee, Corporate Vice President, Microsoft Research & Incubations, and Brandon Pletsch, Practice Leader of Scientific Visualization at Real Chemistry, to learn about the applications and implications of generative AI, specifically GPT-4, in healthcare and other fields. They explore public perceptions of AI, its potential benefits and risks, the importance of ethical considerations and regulatory guidelines, and the concept of equitable access to AI in he...
In this episode, Ajit Singh, PhD, Managing Director and General Partner at Artiman Ventures, shares his insights on various aspects of healthcare, his approach to leadership and decision-making and his thoughts on the future of healthcare. From AI to oncology to neuro technology, Ajit covers it all.
Learn more about the inspiring journey of Jason Gardner, Head of Medical at Real Chemistry, and his views on AI and DE&I in healthcare. From his father's struggle with multiple sclerosis to his strategic approach to medical communications, Jason shares his unique perspectives on how diverse thinking and experiences can bring value to the healthcare industry.
In this episode, National Pharmaceutical Council (NPC) President and CEO John O'Brien, PharmD, MPH, joins Real Chemistry’s Founder and Chairman, Jim Weiss, to discuss the pharmaceutical industry, the value assessment of medicines, the role of government in drug pricing and the importance of research in healthcare policy. Tune in to get the latest insights on the lack of clarity in government guidelines, the hostile environment for the pharmaceutical industry, the shift in benefits and the rise i...
Misinformation in the digital age is a complex problem, but it can be addressed. In this episode, Dr. Geeta Nayyar, former Chief Medical Officer at Salesforce and AT&T, discusses her book, Dead Wrong, and the role of artificial intelligence in healthcare. Tune in to learn more about the importance of trust in the healthcare industry, the role of life sciences companies in combating misinformation and the necessity of health literacy and prevention.
In this episode, Javeria Shahab, President of Medical Education at 21GRAMS, a part of Real Chemistry, discusses the challenges and changes in the medical education industry, building effective teams and the importance of empathy in healthcare communications. Get an insider's look into the industry and hear Javeria's advice for those looking to break into the field.
In this episode, Dr. Sue Desmond-Hellmann, Member of President Biden’s Council of Advisors on Science and Technology and former CEO of the Bill & Melinda Gates Foundation, Mike Huckman, Global Practice Leader of Executive Communications at Real Chemistry, and Jim Weiss, Founder and Chairman at Real Chemistry, discuss the importance of vaccination, the evolution of cancer treatments and the challenges of clinical trials. They also highlight the need for diverse representation in clinical tria...
In this episode, Dr. Julie Gerberding, President and CEO of the Foundation for the National Institutes of Health (FNIH), Dr. Jay Bradner, FNIH board member and former President of the Novartis Institutes for Biomedical Research, and Jim Weiss, Founder and Chairman at Real Chemistry and FNIH board member, discuss the power of collaboration, how trust in science is essential for progress, emerging areas in medicine and the challenges of the current healthcare landscape. Listen to the full episode ...
In this episode, Mark Martin, Managing Director at Houlihan Lokey, and Jim Weiss, Founder and Chairman at Real Chemistry, explore the healthcare marketing and commercialization industry, including the impact of data and technology, trends in acquisitions and deals, and the importance of organic growth and innovation.
Digital medicine is essential for improving healthcare and addressing issues related to access and equity. In the latest episode, learn about the importance of digital medicine, the challenges and opportunities in the industry and the importance of an integrated evidence plan. Plus, CEO and Co-Founder of the Digital Medicine Society (DiMe), Jennifer Goldsack, shares her thoughts on generative AI and advice for young professionals in healthcare. As part of DiMe’s upcoming Integrated Evidence Plan...
Did you know that there are more than 100 types of liver diseases that affect 1.5 billion people worldwide? Join us as we explore the importance of collaboration and innovation in addressing liver health issues, the role of digital health and equity, and the future of liver health with Donna Cryer, J.D., Founder, President and CEO of the Global Liver Institute. Get the inside scoop on the latest developments in the field of liver health and how they can improve patient outcomes and access to car...
Space exploration and research are rapidly advancing, and life sciences is a key component of this progress. Learn more about the opportunities and developments in space R&D and manufacturing, particularly in the life sciences sector, from Maureen Haverty, VP of Investment at Seraphim Space/Generation Space.
In this episode with Biotricity CEO and Founder Waqaas Al-Siddiq, PhD, discover how AI is transforming healthcare and how Biotricity's Bioheart device is helping to manage and prevent cardiac conditions.
Communication is a critical skill for leaders and company culture. In this episode, Real Chemistry Founder and Chairman Jim Weiss is joined by Sally Susman, Chief Corporate Affairs Officer of Pfizer and author of "Breaking Through," who shares her insights on the importance of communication in leadership, building corporate and product brands, and navigating challenging conversations.
Recorded live from SXSW 2023, 7wire Ventures Co-Founder & Managing Partner Lee Shapiro explores how technology, data and collaboration can be used to make healthcare more personalized, efficient and cost-effective, ultimately leading to improved health outcomes.
With tools like ChatGPT and DALL-E dominating news cycles, many people – especially those working in creative jobs – are wondering if they will soon be replaced by the technology known as generative AI. During this session, originally recorded in front of a live audience at SXSW 2023, Sameer Grover, CNS Sr. Specialty Division Manager at AbbVie, and Romain Bogaerts, Director of AI Product Management at Real Chemistry, discuss what impact generative AI is having on the creative process, particular...
Recorded live from SXSW 2023, Alison Woo, Head of Strategy, Planning and Paid Campaigns, Communications & Government Affairs at GSK, shares what a day in her life looks like, what she gathered at SXSW this year and what it means to be disruptive at a company without being too disruptive.
